Author:
Green Douglas R.,Ferguson Thomas A.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference69 articles.
1. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. & Ferguson, T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189?1192 (1995).This study shows for the first time that FasL is functionally and constitutively expressed in the eye ? an immune-privileged site.
2. Igney, F. H., Behrens, C. K. & Krammer, P. H. Tumor counterattack ? concept and reality. Eur. J. Immunol. 30, 725?731 (2000).
3. Restifo, N. P. Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nature Med. 6, 493?495 (2000).
4. Yagita, H., Seino, K., Kayagaki, N. & Okumura, K. CD95 ligand in graft rejection. Nature 379, 682 (1996).
5. Smith, D., Sieg, S. & Kaplan, D. Technical note: aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J. Immunol. 160, 4159?4160 (1998).
Cited by
233 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献